Unknown

Dataset Information

0

Prediagnostic detection of mesothelioma by circulating calretinin and mesothelin - a case-control comparison nested into a prospective cohort of asbestos-exposed workers.


ABSTRACT: Malignant mesothelioma (MM) is strongly associated with a previous asbestos exposure. To improve timely detection of MM in asbestos workers, better screening tools - like minimally-invasive biomarkers - are desirable. Between 2008 and 2018 2,769 patients with benign asbestos-related diseases were recruited to participate in annual screens. Using a nested case-control design the protein markers calretinin and mesothelin were determined by enzyme-linked immunosorbent assays in prediagnostic plasma samples of 34 MM cases as well as 136 matched controls from the cohort. Conditional on a pre-defined specificity of 98% for calretinin and 99% for mesothelin the markers reached individual sensitivities of 31% and 23%, respectively, when including the incident cases with samples taken between one and 15 months before diagnosis. The combination of both markers increased the sensitivity to 46% at 98% specificity. Marker complementation increased with earlier sampling. The marker combination improves the sensitivity of the individual markers, indicating a useful complementation and suggesting that additional markers may further improve the performance. This is the first prospective cohort study to evaluate a detection of MM by calretinin and its combination with mesothelin up to about a year before clinical diagnosis. Whether an earlier diagnosis will result in reduced mortality has yet to be demonstrated.

SUBMITTER: Johnen G 

PROVIDER: S-EPMC6156219 | biostudies-literature | 2018 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Prediagnostic detection of mesothelioma by circulating calretinin and mesothelin - a case-control comparison nested into a prospective cohort of asbestos-exposed workers.

Johnen Georg G   Burek Katarzyna K   Raiko Irina I   Wichert Katharina K   Pesch Beate B   Weber Daniel G DG   Lehnert Martin M   Casjens Swaantje S   Hagemeyer Olaf O   Taeger Dirk D   Brüning Thomas T  

Scientific reports 20180925 1


Malignant mesothelioma (MM) is strongly associated with a previous asbestos exposure. To improve timely detection of MM in asbestos workers, better screening tools - like minimally-invasive biomarkers - are desirable. Between 2008 and 2018 2,769 patients with benign asbestos-related diseases were recruited to participate in annual screens. Using a nested case-control design the protein markers calretinin and mesothelin were determined by enzyme-linked immunosorbent assays in prediagnostic plasma  ...[more]

Similar Datasets

| S-EPMC9776112 | biostudies-literature
| S-EPMC10119131 | biostudies-literature
| S-EPMC8744912 | biostudies-literature
| S-EPMC7682175 | biostudies-literature
| S-EPMC2684196 | biostudies-literature
| S-EPMC4715907 | biostudies-literature
| S-EPMC3790169 | biostudies-other
| S-EPMC8585060 | biostudies-literature
| S-EPMC5652464 | biostudies-literature
| S-EPMC5017649 | biostudies-literature